Digital Health for Obesity Market Overview
The global digital health for obesity market is projected to expand at a CAGR of 23% over the next five years. The market is being supported by the rising global burden of obesity and metabolic disorders, increasing adoption of wearable and connected healthcare technologies, growing emphasis on preventive and continuous care, greater awareness of lifestyle-related health risks, and expanding use of telehealth and virtual care services.
Digital health solutions are transforming obesity management by combining mobile applications, remote monitoring, telemedicine, connected devices, artificial intelligence, and personalized digital interventions. These technologies enable continuous tracking of weight, physical activity, nutrition, medication adherence, and other health indicators while providing patients and healthcare professionals with actionable insights for long-term disease management.
What is Digital Health for Obesity?
Digital health for obesity encompasses technology-enabled solutions designed to support the prevention, monitoring, and management of obesity and related metabolic conditions. These solutions include mobile health applications, wearable devices, connected health platforms, telehealth services, remote patient monitoring, digital coaching, and AI-powered tools.
The growing availability of patient-generated health data is creating opportunities to deliver more personalized and outcome-focused obesity care. Digital platforms can combine information related to lifestyle, activity, nutrition, weight, and treatment adherence to support continuous monitoring and individualized interventions.
The market includes established and emerging companies such as Noom, WW International, MyFitnessPal, Fitbit, Teladoc Health, Sidekick Health, and Eli Lilly and Company. Industry conferences, digital health initiatives, and collaborative programs are also supporting innovation and knowledge sharing across the obesity care ecosystem.
Get Free Sample Report: https://meditechinsights.com/digital-health-for-obesity-market/request-sample/
Role of AI in the Digital Health for Obesity Market
Artificial intelligence is becoming an important technology for improving obesity prevention and management. AI-based solutions can analyze large volumes of patient and lifestyle data to support risk prediction, early identification of health risks, personalized interventions, and continuous monitoring.
AI-powered platforms can provide individualized coaching and recommendations based on behavioral patterns, activity levels, dietary information, and other health indicators. Predictive analytics can help identify individuals who may be at greater risk of obesity-related complications, while AI-enabled clinical decision support can assist healthcare professionals in treatment planning.
The application of AI also extends to medical diagnostics, drug discovery, clinical research, and surgical planning. As AI capabilities become increasingly integrated with digital health platforms, these technologies are expected to support more scalable and personalized approaches to obesity management.
Trends and Future Outlook
Integration of Digital Care with Pharmacotherapy
Digital health platforms are increasingly being combined with pharmacological approaches to obesity management. Telehealth platforms can provide access to consultations, disease-management tools, medication support, behavioral interventions, and home delivery services.
The integration of smart injection devices with mobile applications is also emerging as a way to support medication administration, adherence tracking, patient education, and ongoing monitoring. Such integrated models can connect pharmacotherapy with lifestyle management and digital coaching.
Advanced Monitoring Technologies
Wearables, Internet of Things (IoT) devices, connected health platforms, and other digital technologies are enabling continuous collection of patient-generated health data. These technologies can track parameters such as physical activity, sleep, weight, and other lifestyle indicators.
Real-time data and automated feedback can help users monitor progress and make behavioral adjustments. The increasing availability of connected devices is therefore expanding the capabilities of digital obesity-management platforms.
Integration with Anti-Obesity Medications
The growing use of highly effective anti-obesity medications, including GLP-1-based therapies, is creating new opportunities for digital health platforms. Digital solutions can complement pharmacotherapy by supporting medication adherence, lifestyle modification, treatment monitoring, and communication with healthcare professionals.
Companies such as Eli Lilly and Company are developing digital and technology-enabled approaches around obesity treatment, contributing to the convergence of pharmaceutical and digital health services.
Expansion of Telehealth and Multidisciplinary Care
Telehealth is expanding access to specialized obesity-management services by connecting patients with physicians, psychologists, dietitians, fitness professionals, and other specialists. Video consultations and remote care platforms can reduce geographic barriers while enabling continued interaction between patients and care teams.
Integrated digital platforms increasingly combine virtual and in-person services to provide longer-term support, behavioral counseling, medication management, and lifestyle interventions.
Major Investments and Developments
Investment activity is contributing to the development and expansion of digital obesity-care platforms. In July 2025, Numan secured $60 million to scale its preventive digital health platform and expand screening and preventive care programs.
In May 2025, the World Bank Group reported initiatives aimed at transforming healthcare access in the Pacific Islands with World Bank support, highlighting the broader role of digital and technology-enabled healthcare models in improving access to care.
Segmental Insights
Component Insights
Services Segment
The services segment accounted for the largest share of the digital health for obesity market in 2025. Its leading position is supported by the increasing availability of personalized digital interventions, remote support, self-monitoring tools, behavioral guidance, and continuous feedback.
Digital health services can provide behavioral and psychological support while facilitating communication between patients and multidisciplinary care teams. They can also support clinical decision-making and coordinate interventions across physicians, dietitians, psychologists, fitness professionals, and other healthcare providers.
Software Segment
The software segment is expected to register the fastest growth during the forecast period. Software represents a core component of digital obesity-management ecosystems, supporting behavioral health, self-monitoring, personalized interventions, remote care, and patient engagement.
Key software applications include mobile health applications, telehealth platforms, AI and machine learning algorithms, and Internet of Medical Things (IoMT) platforms. Their scalability, accessibility, and ability to process patient-generated data are increasing their importance in personalized obesity management.
End-Use Insights
Patient Segment
The patient segment dominated the digital health for obesity market in 2025. Increased access to telemedicine, remote monitoring, digital appointment management, medication support, and wellness-tracking tools has strengthened the role of patients as major users of digital obesity-management solutions.
Digital platforms enable patients to monitor health and lifestyle indicators, access medical information, track medications, and receive personalized recommendations. These capabilities support more proactive engagement in disease management and can facilitate continuous communication with healthcare providers.
Provider Segment
The provider segment is expected to grow at the fastest rate during the forecast period. Healthcare providers are increasingly adopting digital tools to improve operational efficiency, clinical decision-making, patient monitoring, and care coordination.
Advanced digital health platforms can facilitate communication among multidisciplinary teams, improve access to patient information, support remote consultations, and enhance patient-management workflows. Digital solutions can also contribute to medical education, professional training, and collaboration among healthcare professionals.
Competitive Landscape Analysis
The global digital health for obesity market comprises technology companies, digital therapeutics providers, healthcare platforms, pharmaceutical companies, and connected-health solution providers. Competition is increasingly centered on personalized care, AI capabilities, remote monitoring, telehealth integration, patient engagement, medication support, and the ability to integrate digital services with broader obesity-management pathways.
Key players include:
- Noom, Inc. (US)
- WW International, Inc. (US)
- MyFitnessPal, Inc. (US)
- Teladoc Health, Inc. (US)
- Fitbit, Inc. (now part of Google) (US)
- WellDoc, Inc. (US)
- Sidekick Health (US)
- Omada Health, Inc. (US)
- Hims & Hers Health, Inc. (US)
- BioAge Labs (US)
Market Strategies
Market participants are focusing on AI-enabled personalization, connected-device integration, remote patient monitoring, digital coaching, and telehealth to strengthen their obesity-care offerings. Partnerships between technology companies, healthcare providers, and pharmaceutical companies are also supporting the integration of digital platforms with pharmacological treatments.
Companies are additionally expanding multidisciplinary care models, improving patient engagement, and developing solutions that combine behavioral modification, medication management, continuous monitoring, and personalized coaching. The increasing convergence of digital health, telemedicine, connected devices, and anti-obesity therapies is expected to remain a significant factor shaping the market over the next five years.
Request a Quote for This Study: https://meditechinsights.com/digital-health-for-obesity-market/quote/12952
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
